Want to join the conversation?
For FY16, $TEL expects net sales of $12-12.8Bil, reflecting 1% actual and 3% organic growth vs. prior year at the mid-point; and adjusted EPS of $3.80-4.20 reflecting double-digit growth versus the prior year. GAAP EPS are expected to be $3.61-4.01, including restructuring and other charges of $0.16, and acquisition related charges of $0.03.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?